Cochrane Abstracts
Interferon beta for secondary progressive multiple sclerosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Interferon Beta for Secondary Progressive Multiple Sclerosis." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/440158/all/Interferon_beta_for_secondary_progressive_multiple_sclerosis.
Interferon beta for secondary progressive multiple sclerosis. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440158/all/Interferon_beta_for_secondary_progressive_multiple_sclerosis. Accessed January 2, 2025.
Interferon beta for secondary progressive multiple sclerosis. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440158/all/Interferon_beta_for_secondary_progressive_multiple_sclerosis
Interferon Beta for Secondary Progressive Multiple Sclerosis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2025 January 02]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/440158/all/Interferon_beta_for_secondary_progressive_multiple_sclerosis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Interferon beta for secondary progressive multiple sclerosis
ID - 440158
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/440158/all/Interferon_beta_for_secondary_progressive_multiple_sclerosis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
